Products

Enso Healthcare collaborates with RDIF to procure Sputnik V vaccines from India and other parts of the world. Russian Direct Investment Fund (RDIF) is Russia’s sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF has played a key role in fighting COVID-19 in Russia. The Fund has selected and funded the most promising testing system (COVID-19 SmartAmp), drug (Avifavir) and vaccine (Sputnik V) for COVID-19. RDIF acts as a catalyst for direct investment in the Russian economy

Sputnik V

91.4% KNOWN EFFICACY | 70+ COUNTRIES

Sputnik Light

79.4% KNOWN EFFICACY | 15+ COUNTRIES